Researcher Profile

Cristina Suarez

Publications

4,291

Citations

Co-Authors

Active Years

Publications

Journal Article Journal of Clinical Oncology Feb 10, 2025

Final overall survival and new ctDNA analysis in MET-driven advanced papillary renal cancer (CALYPSO).

Francesca Jackson-Spence · James Larkin · Poulam Patel · Begoña P. Valderrama +14 more

10.1200/jco.2025.43.5_suppl.444 2 citations

Journal Article New England Journal of Medicine Nov 14, 2024

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

Thomas Powles · James W.F. Catto · Matthew D. Galsky · Hikmat Al-Ahmadie +21 more

10.1056/nejmoa2408154 290 citations

Open Access Journal Article European Urology Jul 01, 2023

Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma

Matthew S. Ernst · Vishal Navani · J. Connor Wells · Frede Donskov +16 more

10.1016/j.eururo.2023.01.001 58 citations

Journal Article Journal of Clinical Oncology May 10, 2023

Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO)

Cristina Suarez · James M.G. Larkin · Poulam Patel · Begoña P. Valderrama +12 more

10.1200/jco.22.01414 47 citations

Open Access Journal Article Future Oncology Jan 01, 2023

LITESPARK-011: belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy

Robert J Motzer · Manuela Schmidinger · Masatoshi Eto · Cristina Suarez +5 more

10.2217/fon-2022-0802 36 citations

Journal Article The Lancet Oncology Jul 01, 2022

Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial

Robert J Motzer · Thomas Powles · Mauricio Burotto · Bernard Escudier +15 more

10.1016/s1470-2045(22)00290-x 277 citations

Open Access Journal Article The Lancet May 01, 2021

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani · Ali Abbas · Fatima Abbas · Mustafa Abbas +6331 more

10.1016/s0140-6736(21)00676-0 1,504 citations

Journal Article New England Journal of Medicine Mar 04, 2021

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Toni K. Choueiri · Thomas Powles · Mauricio Burotto · Bernard Escudier +27 more

10.1056/nejmoa2026982 1,522 citations

Journal Article Journal of Antimicrobial Chemotherapy Dec 20, 2021

Impact of rapid susceptibility testing on antimicrobial therapy and clinical outcomes in Gram-negative bloodstream infections

Vanesa Anton-Vazquez · Cristina Suarez · Timothy Planche

10.1093/jac/dkab449 22 citations

Journal Article Nature Medicine Nov 01, 2019

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Thomas Powles · Mark Kockx · Alejo Rodriguez-Vida · Ignacio Duran +21 more

10.1038/s41591-019-0628-7 533 citations

Publication Timeline

2025

2024

2023

2022

2021

2019

Frequent Co-Authors

6×

3×

3×

2×

2×

2×

2×

2×

2×

2×